RA Capital Nexus Fund II, Director: Climb Bio CLYM Buy · Filed 25/12/15

Trade details

Type: Insider buy
Amount: $464,555.82
Shares · price: 213,099 sh · $2.18 a share
Held after: 3,294,856 sh
Stock: Climb Bio CLYM
Person: RA Capital Nexus Fund IIDirector
Trade date: 25/12/11
Filed: 25/12/15
Days to filing: 4 days

First buy in 1 years

Since the last buy: 1.5 years
Last buy: 24/06/27
Insiders buying this week: 7 insiders
Holding change: +6.9%

Climb Bio trades, last 26 weeks

What else happened in Climb Bio around then

Filed or reported within 30 days of the trade day · 25/11/11~01/10

RA Capital Nexus Fund II's recent trades

RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$45.7M
2,541,250 sh
$45.7M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.4M
133,750 sh
$2.4M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.1M
87,143 sh
$2.1M
Filed 05/06
Traded 05/05
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.3M
53,407 sh
$1.3M
Filed 05/06
Traded 05/06
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$347.3K
14,611 sh
$347.3K
Filed 05/06
Traded 05/06

RA Capital Nexus Fund II, Director — bought $464.6K of Climb Bio CLYM · 213,099 sh @ $2.18 | Whalegun